nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—SLC6A4—Alzheimer's disease	0.247	0.587	CbGaD
Levomilnacipran—CYP2D6—Alzheimer's disease	0.173	0.413	CbGaD
Levomilnacipran—CYP2D6—Rivastigmine—Alzheimer's disease	0.0715	0.213	CbGbCtD
Levomilnacipran—CYP2C19—Memantine—Alzheimer's disease	0.0652	0.194	CbGbCtD
Levomilnacipran—CYP2D6—Donepezil—Alzheimer's disease	0.0572	0.17	CbGbCtD
Levomilnacipran—CYP3A4—Rivastigmine—Alzheimer's disease	0.0455	0.135	CbGbCtD
Levomilnacipran—CYP2D6—Galantamine—Alzheimer's disease	0.0368	0.11	CbGbCtD
Levomilnacipran—CYP3A4—Donepezil—Alzheimer's disease	0.0364	0.108	CbGbCtD
Levomilnacipran—CYP3A4—Galantamine—Alzheimer's disease	0.0234	0.0697	CbGbCtD
Levomilnacipran—SLC6A2—locus ceruleus—Alzheimer's disease	0.00723	0.242	CbGeAlD
Levomilnacipran—CYP2J2—blood vessel—Alzheimer's disease	0.00357	0.12	CbGeAlD
Levomilnacipran—CYP2J2—forebrain—Alzheimer's disease	0.00189	0.0631	CbGeAlD
Levomilnacipran—CYP2J2—telencephalon—Alzheimer's disease	0.00173	0.058	CbGeAlD
Levomilnacipran—Milnacipran—SLC6A4—Alzheimer's disease	0.00159	0.46	CrCbGaD
Levomilnacipran—Pethidine—GRIN2B—Alzheimer's disease	0.00116	0.337	CrCbGaD
Levomilnacipran—CYP2J2—nervous system—Alzheimer's disease	0.00102	0.0343	CbGeAlD
Levomilnacipran—SLC6A4—forebrain—Alzheimer's disease	0.00102	0.034	CbGeAlD
Levomilnacipran—CYP2J2—central nervous system—Alzheimer's disease	0.000986	0.033	CbGeAlD
Levomilnacipran—CYP2J2—cerebellum—Alzheimer's disease	0.000963	0.0322	CbGeAlD
Levomilnacipran—SLC6A4—telencephalon—Alzheimer's disease	0.000935	0.0313	CbGeAlD
Levomilnacipran—SLC6A2—forebrain—Alzheimer's disease	0.000895	0.03	CbGeAlD
Levomilnacipran—SLC6A2—telencephalon—Alzheimer's disease	0.000823	0.0276	CbGeAlD
Levomilnacipran—CYP2J2—brain—Alzheimer's disease	0.000783	0.0262	CbGeAlD
Levomilnacipran—ABCB1—blood vessel—Alzheimer's disease	0.000668	0.0224	CbGeAlD
Levomilnacipran—SLC6A4—nervous system—Alzheimer's disease	0.000552	0.0185	CbGeAlD
Levomilnacipran—SLC6A4—central nervous system—Alzheimer's disease	0.000531	0.0178	CbGeAlD
Levomilnacipran—Dysuria—Donepezil—Alzheimer's disease	0.000499	0.00308	CcSEcCtD
Levomilnacipran—Breast disorder—Rivastigmine—Alzheimer's disease	0.000496	0.00306	CcSEcCtD
Levomilnacipran—Pollakiuria—Donepezil—Alzheimer's disease	0.000493	0.00304	CcSEcCtD
Levomilnacipran—CYP2D6—forebrain—Alzheimer's disease	0.00049	0.0164	CbGeAlD
Levomilnacipran—SLC6A2—nervous system—Alzheimer's disease	0.000486	0.0163	CbGeAlD
Levomilnacipran—Mental disorder—Galantamine—Alzheimer's disease	0.000483	0.00298	CcSEcCtD
Levomilnacipran—Weight decreased—Donepezil—Alzheimer's disease	0.000483	0.00298	CcSEcCtD
Levomilnacipran—Malnutrition—Galantamine—Alzheimer's disease	0.00048	0.00296	CcSEcCtD
Levomilnacipran—Flatulence—Galantamine—Alzheimer's disease	0.000473	0.00292	CcSEcCtD
Levomilnacipran—Angina pectoris—Memantine—Alzheimer's disease	0.000472	0.00291	CcSEcCtD
Levomilnacipran—Tension—Galantamine—Alzheimer's disease	0.000471	0.00291	CcSEcCtD
Levomilnacipran—Dysgeusia—Galantamine—Alzheimer's disease	0.00047	0.0029	CcSEcCtD
Levomilnacipran—SLC6A2—central nervous system—Alzheimer's disease	0.000468	0.0157	CbGeAlD
Levomilnacipran—Urinary tract infection—Donepezil—Alzheimer's disease	0.000463	0.00286	CcSEcCtD
Levomilnacipran—Angina pectoris—Rivastigmine—Alzheimer's disease	0.000462	0.00285	CcSEcCtD
Levomilnacipran—Haematuria—Donepezil—Alzheimer's disease	0.000454	0.0028	CcSEcCtD
Levomilnacipran—Dysuria—Memantine—Alzheimer's disease	0.000453	0.0028	CcSEcCtD
Levomilnacipran—Neutropenia—Memantine—Alzheimer's disease	0.000453	0.0028	CcSEcCtD
Levomilnacipran—Vision blurred—Galantamine—Alzheimer's disease	0.000452	0.00279	CcSEcCtD
Levomilnacipran—CYP2D6—telencephalon—Alzheimer's disease	0.000451	0.0151	CbGeAlD
Levomilnacipran—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.00045	0.00278	CcSEcCtD
Levomilnacipran—Tremor—Galantamine—Alzheimer's disease	0.00045	0.00278	CcSEcCtD
Levomilnacipran—Pollakiuria—Memantine—Alzheimer's disease	0.000448	0.00276	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Memantine—Alzheimer's disease	0.000446	0.00276	CcSEcCtD
Levomilnacipran—Dysuria—Rivastigmine—Alzheimer's disease	0.000443	0.00274	CcSEcCtD
Levomilnacipran—Agitation—Galantamine—Alzheimer's disease	0.000441	0.00272	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.000441	0.00272	CcSEcCtD
Levomilnacipran—Weight decreased—Memantine—Alzheimer's disease	0.000438	0.00271	CcSEcCtD
Levomilnacipran—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000438	0.0027	CcSEcCtD
Levomilnacipran—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000437	0.0027	CcSEcCtD
Levomilnacipran—Syncope—Galantamine—Alzheimer's disease	0.00043	0.00266	CcSEcCtD
Levomilnacipran—Weight decreased—Rivastigmine—Alzheimer's disease	0.000429	0.00265	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000428	0.00265	CcSEcCtD
Levomilnacipran—Hepatitis—Donepezil—Alzheimer's disease	0.000427	0.00264	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000425	0.00262	CcSEcCtD
Levomilnacipran—Hallucination—Donepezil—Alzheimer's disease	0.000425	0.00262	CcSEcCtD
Levomilnacipran—Palpitations—Galantamine—Alzheimer's disease	0.000424	0.00262	CcSEcCtD
Levomilnacipran—SLC6A4—brain—Alzheimer's disease	0.000422	0.0141	CbGeAlD
Levomilnacipran—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000422	0.00261	CcSEcCtD
Levomilnacipran—Loss of consciousness—Galantamine—Alzheimer's disease	0.000422	0.0026	CcSEcCtD
Levomilnacipran—Oedema peripheral—Donepezil—Alzheimer's disease	0.000421	0.0026	CcSEcCtD
Levomilnacipran—Urinary tract infection—Memantine—Alzheimer's disease	0.00042	0.00259	CcSEcCtD
Levomilnacipran—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000419	0.00259	CcSEcCtD
Levomilnacipran—Urethral disorder—Donepezil—Alzheimer's disease	0.000419	0.00259	CcSEcCtD
Levomilnacipran—Convulsion—Galantamine—Alzheimer's disease	0.000416	0.00257	CcSEcCtD
Levomilnacipran—Hypertension—Galantamine—Alzheimer's disease	0.000414	0.00256	CcSEcCtD
Levomilnacipran—Haematuria—Memantine—Alzheimer's disease	0.000412	0.00254	CcSEcCtD
Levomilnacipran—Pethidine—SLC6A4—Alzheimer's disease	0.000411	0.119	CrCbGaD
Levomilnacipran—Urinary tract infection—Rivastigmine—Alzheimer's disease	0.000411	0.00254	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Memantine—Alzheimer's disease	0.000409	0.00252	CcSEcCtD
Levomilnacipran—Chest pain—Galantamine—Alzheimer's disease	0.000408	0.00252	CcSEcCtD
Levomilnacipran—Anxiety—Galantamine—Alzheimer's disease	0.000407	0.00251	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000406	0.00251	CcSEcCtD
Levomilnacipran—Haematuria—Rivastigmine—Alzheimer's disease	0.000403	0.00249	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.0004	0.00247	CcSEcCtD
Levomilnacipran—Dry mouth—Galantamine—Alzheimer's disease	0.0004	0.00247	CcSEcCtD
Levomilnacipran—ABCB1—embryo—Alzheimer's disease	0.000399	0.0133	CbGeAlD
Levomilnacipran—Hepatitis—Memantine—Alzheimer's disease	0.000388	0.0024	CcSEcCtD
Levomilnacipran—Hallucination—Memantine—Alzheimer's disease	0.000386	0.00238	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Memantine—Alzheimer's disease	0.000386	0.00238	CcSEcCtD
Levomilnacipran—Shock—Galantamine—Alzheimer's disease	0.000385	0.00238	CcSEcCtD
Levomilnacipran—Nervous system disorder—Galantamine—Alzheimer's disease	0.000384	0.00237	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000383	0.00237	CcSEcCtD
Levomilnacipran—Chills—Donepezil—Alzheimer's disease	0.000383	0.00237	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Memantine—Alzheimer's disease	0.000383	0.00237	CcSEcCtD
Levomilnacipran—Tachycardia—Galantamine—Alzheimer's disease	0.000382	0.00236	CcSEcCtD
Levomilnacipran—Oedema peripheral—Memantine—Alzheimer's disease	0.000382	0.00236	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Memantine—Alzheimer's disease	0.000381	0.00235	CcSEcCtD
Levomilnacipran—Skin disorder—Galantamine—Alzheimer's disease	0.00038	0.00235	CcSEcCtD
Levomilnacipran—Urethral disorder—Memantine—Alzheimer's disease	0.00038	0.00235	CcSEcCtD
Levomilnacipran—Hepatitis—Rivastigmine—Alzheimer's disease	0.000379	0.00234	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000379	0.00234	CcSEcCtD
Levomilnacipran—Hallucination—Rivastigmine—Alzheimer's disease	0.000378	0.00233	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000378	0.00233	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000375	0.00231	CcSEcCtD
Levomilnacipran—Mental disorder—Donepezil—Alzheimer's disease	0.000374	0.00231	CcSEcCtD
Levomilnacipran—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000374	0.00231	CcSEcCtD
Levomilnacipran—Anorexia—Galantamine—Alzheimer's disease	0.000373	0.00231	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.000373	0.0023	CcSEcCtD
Levomilnacipran—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000372	0.0023	CcSEcCtD
Levomilnacipran—Malnutrition—Donepezil—Alzheimer's disease	0.000372	0.0023	CcSEcCtD
Levomilnacipran—SLC6A2—brain—Alzheimer's disease	0.000371	0.0124	CbGeAlD
Levomilnacipran—Erythema multiforme—Memantine—Alzheimer's disease	0.000367	0.00226	CcSEcCtD
Levomilnacipran—Flatulence—Donepezil—Alzheimer's disease	0.000366	0.00226	CcSEcCtD
Levomilnacipran—Hypotension—Galantamine—Alzheimer's disease	0.000366	0.00226	CcSEcCtD
Levomilnacipran—Tension—Donepezil—Alzheimer's disease	0.000365	0.00225	CcSEcCtD
Levomilnacipran—Dysgeusia—Donepezil—Alzheimer's disease	0.000364	0.00225	CcSEcCtD
Levomilnacipran—Eye disorder—Memantine—Alzheimer's disease	0.000362	0.00224	CcSEcCtD
Levomilnacipran—Cardiac disorder—Memantine—Alzheimer's disease	0.00036	0.00222	CcSEcCtD
Levomilnacipran—Flushing—Memantine—Alzheimer's disease	0.00036	0.00222	CcSEcCtD
Levomilnacipran—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000359	0.00222	CcSEcCtD
Levomilnacipran—Eye disorder—Rivastigmine—Alzheimer's disease	0.000355	0.00219	CcSEcCtD
Levomilnacipran—Insomnia—Galantamine—Alzheimer's disease	0.000354	0.00219	CcSEcCtD
Levomilnacipran—ABCB1—forebrain—Alzheimer's disease	0.000353	0.0118	CbGeAlD
Levomilnacipran—Flushing—Rivastigmine—Alzheimer's disease	0.000352	0.00217	CcSEcCtD
Levomilnacipran—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000352	0.00217	CcSEcCtD
Levomilnacipran—Angiopathy—Memantine—Alzheimer's disease	0.000352	0.00217	CcSEcCtD
Levomilnacipran—Paraesthesia—Galantamine—Alzheimer's disease	0.000352	0.00217	CcSEcCtD
Levomilnacipran—Vision blurred—Donepezil—Alzheimer's disease	0.00035	0.00216	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Memantine—Alzheimer's disease	0.00035	0.00216	CcSEcCtD
Levomilnacipran—Tremor—Donepezil—Alzheimer's disease	0.000348	0.00215	CcSEcCtD
Levomilnacipran—Somnolence—Galantamine—Alzheimer's disease	0.000348	0.00215	CcSEcCtD
Levomilnacipran—Chills—Memantine—Alzheimer's disease	0.000348	0.00215	CcSEcCtD
Levomilnacipran—Dyspepsia—Galantamine—Alzheimer's disease	0.000345	0.00213	CcSEcCtD
Levomilnacipran—Angiopathy—Rivastigmine—Alzheimer's disease	0.000344	0.00213	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000342	0.00211	CcSEcCtD
Levomilnacipran—Agitation—Donepezil—Alzheimer's disease	0.000342	0.00211	CcSEcCtD
Levomilnacipran—Chills—Rivastigmine—Alzheimer's disease	0.00034	0.0021	CcSEcCtD
Levomilnacipran—Decreased appetite—Galantamine—Alzheimer's disease	0.00034	0.0021	CcSEcCtD
Levomilnacipran—Mental disorder—Memantine—Alzheimer's disease	0.00034	0.0021	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000338	0.00209	CcSEcCtD
Levomilnacipran—Malnutrition—Memantine—Alzheimer's disease	0.000338	0.00208	CcSEcCtD
Levomilnacipran—Fatigue—Galantamine—Alzheimer's disease	0.000338	0.00208	CcSEcCtD
Levomilnacipran—Constipation—Galantamine—Alzheimer's disease	0.000335	0.00207	CcSEcCtD
Levomilnacipran—Syncope—Donepezil—Alzheimer's disease	0.000333	0.00206	CcSEcCtD
Levomilnacipran—Flatulence—Memantine—Alzheimer's disease	0.000333	0.00205	CcSEcCtD
Levomilnacipran—Mental disorder—Rivastigmine—Alzheimer's disease	0.000332	0.00205	CcSEcCtD
Levomilnacipran—Tension—Memantine—Alzheimer's disease	0.000331	0.00205	CcSEcCtD
Levomilnacipran—Dysgeusia—Memantine—Alzheimer's disease	0.000331	0.00204	CcSEcCtD
Levomilnacipran—Malnutrition—Rivastigmine—Alzheimer's disease	0.00033	0.00204	CcSEcCtD
Levomilnacipran—Loss of consciousness—Donepezil—Alzheimer's disease	0.000327	0.00202	CcSEcCtD
Levomilnacipran—Flatulence—Rivastigmine—Alzheimer's disease	0.000325	0.00201	CcSEcCtD
Levomilnacipran—ABCB1—telencephalon—Alzheimer's disease	0.000324	0.0109	CbGeAlD
Levomilnacipran—Tension—Rivastigmine—Alzheimer's disease	0.000324	0.002	CcSEcCtD
Levomilnacipran—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000323	0.002	CcSEcCtD
Levomilnacipran—Convulsion—Donepezil—Alzheimer's disease	0.000322	0.00199	CcSEcCtD
Levomilnacipran—Hypertension—Donepezil—Alzheimer's disease	0.000321	0.00198	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00032	0.00198	CcSEcCtD
Levomilnacipran—Vision blurred—Memantine—Alzheimer's disease	0.000318	0.00196	CcSEcCtD
Levomilnacipran—Chest pain—Donepezil—Alzheimer's disease	0.000317	0.00195	CcSEcCtD
Levomilnacipran—Tremor—Memantine—Alzheimer's disease	0.000316	0.00195	CcSEcCtD
Levomilnacipran—Anxiety—Donepezil—Alzheimer's disease	0.000315	0.00195	CcSEcCtD
Levomilnacipran—Vision blurred—Rivastigmine—Alzheimer's disease	0.000311	0.00192	CcSEcCtD
Levomilnacipran—Agitation—Memantine—Alzheimer's disease	0.00031	0.00192	CcSEcCtD
Levomilnacipran—Dry mouth—Donepezil—Alzheimer's disease	0.00031	0.00191	CcSEcCtD
Levomilnacipran—Abdominal pain—Galantamine—Alzheimer's disease	0.00031	0.00191	CcSEcCtD
Levomilnacipran—Body temperature increased—Galantamine—Alzheimer's disease	0.00031	0.00191	CcSEcCtD
Levomilnacipran—Tremor—Rivastigmine—Alzheimer's disease	0.000309	0.00191	CcSEcCtD
Levomilnacipran—CYP2C8—brain—Alzheimer's disease	0.000305	0.0102	CbGeAlD
Levomilnacipran—Agitation—Rivastigmine—Alzheimer's disease	0.000304	0.00187	CcSEcCtD
Levomilnacipran—Syncope—Memantine—Alzheimer's disease	0.000303	0.00187	CcSEcCtD
Levomilnacipran—Leukopenia—Memantine—Alzheimer's disease	0.000302	0.00187	CcSEcCtD
Levomilnacipran—Infection—Donepezil—Alzheimer's disease	0.000301	0.00186	CcSEcCtD
Levomilnacipran—Shock—Donepezil—Alzheimer's disease	0.000299	0.00184	CcSEcCtD
Levomilnacipran—Palpitations—Memantine—Alzheimer's disease	0.000298	0.00184	CcSEcCtD
Levomilnacipran—Nervous system disorder—Donepezil—Alzheimer's disease	0.000298	0.00184	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000297	0.00183	CcSEcCtD
Levomilnacipran—Loss of consciousness—Memantine—Alzheimer's disease	0.000297	0.00183	CcSEcCtD
Levomilnacipran—Syncope—Rivastigmine—Alzheimer's disease	0.000296	0.00183	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000293	0.00181	CcSEcCtD
Levomilnacipran—Convulsion—Memantine—Alzheimer's disease	0.000293	0.00181	CcSEcCtD
Levomilnacipran—Palpitations—Rivastigmine—Alzheimer's disease	0.000292	0.0018	CcSEcCtD
Levomilnacipran—Hypertension—Memantine—Alzheimer's disease	0.000291	0.0018	CcSEcCtD
Levomilnacipran—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00029	0.00179	CcSEcCtD
Levomilnacipran—Anorexia—Donepezil—Alzheimer's disease	0.000289	0.00179	CcSEcCtD
Levomilnacipran—Pethidine—CYP2D6—Alzheimer's disease	0.000289	0.0837	CrCbGaD
Levomilnacipran—Hypersensitivity—Galantamine—Alzheimer's disease	0.000289	0.00178	CcSEcCtD
Levomilnacipran—Chest pain—Memantine—Alzheimer's disease	0.000287	0.00178	CcSEcCtD
Levomilnacipran—Anxiety—Memantine—Alzheimer's disease	0.000286	0.00177	CcSEcCtD
Levomilnacipran—Convulsion—Rivastigmine—Alzheimer's disease	0.000286	0.00177	CcSEcCtD
Levomilnacipran—Hypertension—Rivastigmine—Alzheimer's disease	0.000285	0.00176	CcSEcCtD
Levomilnacipran—Hypotension—Donepezil—Alzheimer's disease	0.000284	0.00175	CcSEcCtD
Levomilnacipran—Chest pain—Rivastigmine—Alzheimer's disease	0.000281	0.00174	CcSEcCtD
Levomilnacipran—Dry mouth—Memantine—Alzheimer's disease	0.000281	0.00174	CcSEcCtD
Levomilnacipran—Asthenia—Galantamine—Alzheimer's disease	0.000281	0.00174	CcSEcCtD
Levomilnacipran—Anxiety—Rivastigmine—Alzheimer's disease	0.00028	0.00173	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000279	0.00172	CcSEcCtD
Levomilnacipran—Dry mouth—Rivastigmine—Alzheimer's disease	0.000275	0.0017	CcSEcCtD
Levomilnacipran—Insomnia—Donepezil—Alzheimer's disease	0.000274	0.0017	CcSEcCtD
Levomilnacipran—Infection—Memantine—Alzheimer's disease	0.000274	0.00169	CcSEcCtD
Levomilnacipran—Paraesthesia—Donepezil—Alzheimer's disease	0.000273	0.00168	CcSEcCtD
Levomilnacipran—Shock—Memantine—Alzheimer's disease	0.000271	0.00167	CcSEcCtD
Levomilnacipran—Dyspnoea—Donepezil—Alzheimer's disease	0.000271	0.00167	CcSEcCtD
Levomilnacipran—CYP3A4—nervous system—Alzheimer's disease	0.00027	0.00905	CbGeAlD
Levomilnacipran—Nervous system disorder—Memantine—Alzheimer's disease	0.00027	0.00167	CcSEcCtD
Levomilnacipran—Somnolence—Donepezil—Alzheimer's disease	0.00027	0.00167	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Memantine—Alzheimer's disease	0.00027	0.00167	CcSEcCtD
Levomilnacipran—Tachycardia—Memantine—Alzheimer's disease	0.000269	0.00166	CcSEcCtD
Levomilnacipran—Diarrhoea—Galantamine—Alzheimer's disease	0.000268	0.00165	CcSEcCtD
Levomilnacipran—Infection—Rivastigmine—Alzheimer's disease	0.000268	0.00165	CcSEcCtD
Levomilnacipran—Skin disorder—Memantine—Alzheimer's disease	0.000268	0.00165	CcSEcCtD
Levomilnacipran—Dyspepsia—Donepezil—Alzheimer's disease	0.000267	0.00165	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Memantine—Alzheimer's disease	0.000266	0.00165	CcSEcCtD
Levomilnacipran—CYP2D6—nervous system—Alzheimer's disease	0.000266	0.00891	CbGeAlD
Levomilnacipran—Shock—Rivastigmine—Alzheimer's disease	0.000265	0.00164	CcSEcCtD
Levomilnacipran—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000264	0.00163	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000264	0.00163	CcSEcCtD
Levomilnacipran—Decreased appetite—Donepezil—Alzheimer's disease	0.000264	0.00163	CcSEcCtD
Levomilnacipran—Tachycardia—Rivastigmine—Alzheimer's disease	0.000263	0.00162	CcSEcCtD
Levomilnacipran—Anorexia—Memantine—Alzheimer's disease	0.000263	0.00162	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000262	0.00162	CcSEcCtD
Levomilnacipran—Skin disorder—Rivastigmine—Alzheimer's disease	0.000262	0.00162	CcSEcCtD
Levomilnacipran—Fatigue—Donepezil—Alzheimer's disease	0.000262	0.00162	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000261	0.00161	CcSEcCtD
Levomilnacipran—CYP3A4—central nervous system—Alzheimer's disease	0.00026	0.00871	CbGeAlD
Levomilnacipran—Constipation—Donepezil—Alzheimer's disease	0.00026	0.0016	CcSEcCtD
Levomilnacipran—Dizziness—Galantamine—Alzheimer's disease	0.000259	0.0016	CcSEcCtD
Levomilnacipran—Hypotension—Memantine—Alzheimer's disease	0.000257	0.00159	CcSEcCtD
Levomilnacipran—Anorexia—Rivastigmine—Alzheimer's disease	0.000257	0.00159	CcSEcCtD
Levomilnacipran—CYP2D6—central nervous system—Alzheimer's disease	0.000256	0.00858	CbGeAlD
Levomilnacipran—Hypotension—Rivastigmine—Alzheimer's disease	0.000252	0.00156	CcSEcCtD
Levomilnacipran—CYP2D6—cerebellum—Alzheimer's disease	0.00025	0.00838	CbGeAlD
Levomilnacipran—Insomnia—Memantine—Alzheimer's disease	0.000249	0.00154	CcSEcCtD
Levomilnacipran—Vomiting—Galantamine—Alzheimer's disease	0.000249	0.00154	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000248	0.00153	CcSEcCtD
Levomilnacipran—Paraesthesia—Memantine—Alzheimer's disease	0.000247	0.00153	CcSEcCtD
Levomilnacipran—Rash—Galantamine—Alzheimer's disease	0.000247	0.00152	CcSEcCtD
Levomilnacipran—Dermatitis—Galantamine—Alzheimer's disease	0.000247	0.00152	CcSEcCtD
Levomilnacipran—Dyspnoea—Memantine—Alzheimer's disease	0.000246	0.00152	CcSEcCtD
Levomilnacipran—Headache—Galantamine—Alzheimer's disease	0.000245	0.00151	CcSEcCtD
Levomilnacipran—Somnolence—Memantine—Alzheimer's disease	0.000245	0.00151	CcSEcCtD
Levomilnacipran—Insomnia—Rivastigmine—Alzheimer's disease	0.000244	0.00151	CcSEcCtD
Levomilnacipran—Dyspepsia—Memantine—Alzheimer's disease	0.000243	0.0015	CcSEcCtD
Levomilnacipran—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000242	0.00149	CcSEcCtD
Levomilnacipran—Urticaria—Donepezil—Alzheimer's disease	0.000241	0.00149	CcSEcCtD
Levomilnacipran—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00024	0.00148	CcSEcCtD
Levomilnacipran—Abdominal pain—Donepezil—Alzheimer's disease	0.00024	0.00148	CcSEcCtD
Levomilnacipran—Body temperature increased—Donepezil—Alzheimer's disease	0.00024	0.00148	CcSEcCtD
Levomilnacipran—Somnolence—Rivastigmine—Alzheimer's disease	0.00024	0.00148	CcSEcCtD
Levomilnacipran—Decreased appetite—Memantine—Alzheimer's disease	0.00024	0.00148	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000238	0.00147	CcSEcCtD
Levomilnacipran—Fatigue—Memantine—Alzheimer's disease	0.000238	0.00147	CcSEcCtD
Levomilnacipran—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000237	0.00147	CcSEcCtD
Levomilnacipran—Constipation—Memantine—Alzheimer's disease	0.000236	0.00146	CcSEcCtD
Levomilnacipran—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000234	0.00145	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000233	0.00144	CcSEcCtD
Levomilnacipran—Nausea—Galantamine—Alzheimer's disease	0.000233	0.00144	CcSEcCtD
Levomilnacipran—Fatigue—Rivastigmine—Alzheimer's disease	0.000232	0.00144	CcSEcCtD
Levomilnacipran—Constipation—Rivastigmine—Alzheimer's disease	0.000231	0.00142	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000225	0.00139	CcSEcCtD
Levomilnacipran—Hypersensitivity—Donepezil—Alzheimer's disease	0.000224	0.00138	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00022	0.00136	CcSEcCtD
Levomilnacipran—Urticaria—Memantine—Alzheimer's disease	0.000219	0.00135	CcSEcCtD
Levomilnacipran—Body temperature increased—Memantine—Alzheimer's disease	0.000218	0.00135	CcSEcCtD
Levomilnacipran—Abdominal pain—Memantine—Alzheimer's disease	0.000218	0.00135	CcSEcCtD
Levomilnacipran—Asthenia—Donepezil—Alzheimer's disease	0.000218	0.00134	CcSEcCtD
Levomilnacipran—Pruritus—Donepezil—Alzheimer's disease	0.000215	0.00133	CcSEcCtD
Levomilnacipran—Urticaria—Rivastigmine—Alzheimer's disease	0.000214	0.00132	CcSEcCtD
Levomilnacipran—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000213	0.00132	CcSEcCtD
Levomilnacipran—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000213	0.00132	CcSEcCtD
Levomilnacipran—Diarrhoea—Donepezil—Alzheimer's disease	0.000208	0.00128	CcSEcCtD
Levomilnacipran—CYP2D6—brain—Alzheimer's disease	0.000203	0.00681	CbGeAlD
Levomilnacipran—Hypersensitivity—Memantine—Alzheimer's disease	0.000203	0.00125	CcSEcCtD
Levomilnacipran—Dizziness—Donepezil—Alzheimer's disease	0.000201	0.00124	CcSEcCtD
Levomilnacipran—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000199	0.00123	CcSEcCtD
Levomilnacipran—Asthenia—Memantine—Alzheimer's disease	0.000198	0.00122	CcSEcCtD
Levomilnacipran—Pruritus—Memantine—Alzheimer's disease	0.000195	0.0012	CcSEcCtD
Levomilnacipran—Asthenia—Rivastigmine—Alzheimer's disease	0.000193	0.00119	CcSEcCtD
Levomilnacipran—Vomiting—Donepezil—Alzheimer's disease	0.000193	0.00119	CcSEcCtD
Levomilnacipran—ABCB1—nervous system—Alzheimer's disease	0.000191	0.00641	CbGeAlD
Levomilnacipran—Rash—Donepezil—Alzheimer's disease	0.000191	0.00118	CcSEcCtD
Levomilnacipran—Dermatitis—Donepezil—Alzheimer's disease	0.000191	0.00118	CcSEcCtD
Levomilnacipran—Pruritus—Rivastigmine—Alzheimer's disease	0.000191	0.00118	CcSEcCtD
Levomilnacipran—Headache—Donepezil—Alzheimer's disease	0.00019	0.00117	CcSEcCtD
Levomilnacipran—Diarrhoea—Memantine—Alzheimer's disease	0.000189	0.00116	CcSEcCtD
Levomilnacipran—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000184	0.00114	CcSEcCtD
Levomilnacipran—ABCB1—central nervous system—Alzheimer's disease	0.000184	0.00617	CbGeAlD
Levomilnacipran—Dizziness—Memantine—Alzheimer's disease	0.000182	0.00113	CcSEcCtD
Levomilnacipran—Nausea—Donepezil—Alzheimer's disease	0.00018	0.00111	CcSEcCtD
Levomilnacipran—ABCB1—cerebellum—Alzheimer's disease	0.00018	0.00603	CbGeAlD
Levomilnacipran—Dizziness—Rivastigmine—Alzheimer's disease	0.000178	0.0011	CcSEcCtD
Levomilnacipran—Vomiting—Memantine—Alzheimer's disease	0.000175	0.00108	CcSEcCtD
Levomilnacipran—Rash—Memantine—Alzheimer's disease	0.000174	0.00107	CcSEcCtD
Levomilnacipran—Dermatitis—Memantine—Alzheimer's disease	0.000174	0.00107	CcSEcCtD
Levomilnacipran—Headache—Memantine—Alzheimer's disease	0.000173	0.00107	CcSEcCtD
Levomilnacipran—Vomiting—Rivastigmine—Alzheimer's disease	0.000171	0.00106	CcSEcCtD
Levomilnacipran—Rash—Rivastigmine—Alzheimer's disease	0.00017	0.00105	CcSEcCtD
Levomilnacipran—Dermatitis—Rivastigmine—Alzheimer's disease	0.00017	0.00105	CcSEcCtD
Levomilnacipran—Headache—Rivastigmine—Alzheimer's disease	0.000169	0.00104	CcSEcCtD
Levomilnacipran—Nausea—Memantine—Alzheimer's disease	0.000164	0.00101	CcSEcCtD
Levomilnacipran—Nausea—Rivastigmine—Alzheimer's disease	0.00016	0.000989	CcSEcCtD
Levomilnacipran—ABCB1—brain—Alzheimer's disease	0.000146	0.0049	CbGeAlD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	4.01e-05	0.000829	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ACHE—Alzheimer's disease	3.93e-05	0.000813	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	3.93e-05	0.000813	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—TGFB1—Alzheimer's disease	3.91e-05	0.000809	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—INPP5D—Alzheimer's disease	3.89e-05	0.000804	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—MAOB—Alzheimer's disease	3.81e-05	0.000788	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ENO1—Alzheimer's disease	3.69e-05	0.000762	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS1—Alzheimer's disease	3.69e-05	0.000762	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CYP2D6—Alzheimer's disease	3.61e-05	0.000747	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—MAPK8—Alzheimer's disease	3.57e-05	0.000739	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	3.46e-05	0.000716	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—BCHE—Alzheimer's disease	3.43e-05	0.000709	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—TGFB1—Alzheimer's disease	3.36e-05	0.000695	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	3.34e-05	0.000691	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PLCB1—Alzheimer's disease	3.23e-05	0.000669	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	3.17e-05	0.000656	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ABCA1—Alzheimer's disease	3.13e-05	0.000648	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL1B—Alzheimer's disease	3.11e-05	0.000644	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CASP3—Alzheimer's disease	3.11e-05	0.000643	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	3.07e-05	0.000635	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—DHCR24—Alzheimer's disease	3.05e-05	0.000631	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—VEGFA—Alzheimer's disease	3.04e-05	0.00063	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—PTGS1—Alzheimer's disease	2.89e-05	0.000597	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	2.86e-05	0.00059	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.84e-05	0.000588	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	2.84e-05	0.000586	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	2.83e-05	0.000586	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	2.79e-05	0.000578	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	2.79e-05	0.000578	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DHCR24—Alzheimer's disease	2.72e-05	0.000563	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARGC1A—Alzheimer's disease	2.7e-05	0.000559	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—HMOX1—Alzheimer's disease	2.69e-05	0.000556	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DHCR24—Alzheimer's disease	2.66e-05	0.000549	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—VEGFA—Alzheimer's disease	2.64e-05	0.000545	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CA4—Alzheimer's disease	2.59e-05	0.000536	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—Alzheimer's disease	2.54e-05	0.000525	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.53e-05	0.000524	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DHCR24—Alzheimer's disease	2.5e-05	0.000518	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—TP53—Alzheimer's disease	2.49e-05	0.000515	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—LPL—Alzheimer's disease	2.46e-05	0.000509	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GAPDHS—Alzheimer's disease	2.44e-05	0.000504	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TGFB1—Alzheimer's disease	2.42e-05	0.0005	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CA4—Alzheimer's disease	2.31e-05	0.000479	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ATP5A1—Alzheimer's disease	2.31e-05	0.000478	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	2.3e-05	0.000476	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—IL6—Alzheimer's disease	2.28e-05	0.000472	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—A2M—Alzheimer's disease	2.26e-05	0.000468	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—TNF—Alzheimer's disease	2.26e-05	0.000467	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CA4—Alzheimer's disease	2.26e-05	0.000467	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—MTHFR—Alzheimer's disease	2.21e-05	0.000458	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLD3—Alzheimer's disease	2.2e-05	0.000456	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.2e-05	0.000456	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.18e-05	0.000451	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GAPDHS—Alzheimer's disease	2.18e-05	0.00045	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CA4—Alzheimer's disease	2.13e-05	0.00044	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	2.12e-05	0.000439	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HSD17B10—Alzheimer's disease	2.11e-05	0.000437	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	2.1e-05	0.000434	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	2.07e-05	0.000428	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CALM1—Alzheimer's disease	2.07e-05	0.000428	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	2.07e-05	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ATP5A1—Alzheimer's disease	2.06e-05	0.000427	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—APOE—Alzheimer's disease	2.06e-05	0.000426	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CAV1—Alzheimer's disease	2.04e-05	0.000422	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP46A1—Alzheimer's disease	2.03e-05	0.000421	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	2.01e-05	0.000416	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GAPDHS—Alzheimer's disease	2e-05	0.000414	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	1.99e-05	0.000412	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLD3—Alzheimer's disease	1.97e-05	0.000407	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	1.97e-05	0.000407	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ND1—Alzheimer's disease	1.97e-05	0.000406	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	1.95e-05	0.000402	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	1.94e-05	0.000402	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLD3—Alzheimer's disease	1.92e-05	0.000397	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.92e-05	0.000397	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ATP5A1—Alzheimer's disease	1.9e-05	0.000392	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HSD17B10—Alzheimer's disease	1.89e-05	0.00039	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.84e-05	0.000381	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	1.84e-05	0.000381	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP46A1—Alzheimer's disease	1.82e-05	0.000376	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLD3—Alzheimer's disease	1.81e-05	0.000374	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARG—Alzheimer's disease	1.8e-05	0.000371	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	1.79e-05	0.000369	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	1.77e-05	0.000367	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—INS—Alzheimer's disease	1.76e-05	0.000364	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.76e-05	0.000363	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ND1—Alzheimer's disease	1.75e-05	0.000363	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	1.74e-05	0.00036	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HSD17B10—Alzheimer's disease	1.74e-05	0.000359	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.71e-05	0.000355	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ND1—Alzheimer's disease	1.71e-05	0.000354	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CYP46A1—Alzheimer's disease	1.67e-05	0.000345	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	1.65e-05	0.000342	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.64e-05	0.000339	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ND1—Alzheimer's disease	1.61e-05	0.000334	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.57e-05	0.000324	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NOS3—Alzheimer's disease	1.54e-05	0.000319	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	1.53e-05	0.000317	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.51e-05	0.000313	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PTGS2—Alzheimer's disease	1.41e-05	0.000292	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	1.41e-05	0.000291	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.39e-05	0.000288	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.38e-05	0.000285	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.35e-05	0.000279	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.31e-05	0.000271	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	1.3e-05	0.000269	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.27e-05	0.000262	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.27e-05	0.000262	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	1.25e-05	0.000258	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.24e-05	0.000257	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.23e-05	0.000254	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.21e-05	0.000251	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	1.19e-05	0.000247	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.18e-05	0.000245	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.17e-05	0.000242	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.16e-05	0.000239	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.14e-05	0.000237	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.13e-05	0.000235	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—TPI1—Alzheimer's disease	1.13e-05	0.000234	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CHAT—Alzheimer's disease	1.13e-05	0.000234	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.13e-05	0.000233	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	1.12e-05	0.000231	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CHAT—Alzheimer's disease	1.1e-05	0.000228	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—TPI1—Alzheimer's disease	1.1e-05	0.000228	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.09e-05	0.000226	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MAOB—Alzheimer's disease	1.08e-05	0.000224	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MAOB—Alzheimer's disease	1.06e-05	0.000219	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.05e-05	0.000218	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GAPDH—Alzheimer's disease	1.04e-05	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CHAT—Alzheimer's disease	1.04e-05	0.000215	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—TPI1—Alzheimer's disease	1.04e-05	0.000215	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.03e-05	0.000213	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.02e-05	0.000211	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GAPDH—Alzheimer's disease	1.02e-05	0.000211	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—A2M—Alzheimer's disease	1.01e-05	0.000208	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.01e-05	0.000208	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MAOB—Alzheimer's disease	9.97e-06	0.000206	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—A2M—Alzheimer's disease	9.83e-06	0.000203	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	9.83e-06	0.000203	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ACHE—Alzheimer's disease	9.82e-06	0.000203	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	9.71e-06	0.000201	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GAPDH—Alzheimer's disease	9.59e-06	0.000198	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—A2M—Alzheimer's disease	9.27e-06	0.000192	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ENO1—Alzheimer's disease	9.2e-06	0.00019	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	9.2e-06	0.00019	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	9.02e-06	0.000187	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	8.98e-06	0.000186	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ACHE—Alzheimer's disease	8.76e-06	0.000181	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INPP5D—Alzheimer's disease	8.66e-06	0.000179	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ACHE—Alzheimer's disease	8.55e-06	0.000177	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—BCHE—Alzheimer's disease	8.55e-06	0.000177	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INPP5D—Alzheimer's disease	8.46e-06	0.000175	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	8.3e-06	0.000172	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ENO1—Alzheimer's disease	8.21e-06	0.00017	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS1—Alzheimer's disease	8.21e-06	0.00017	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	8.07e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ACHE—Alzheimer's disease	8.06e-06	0.000167	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CYP2D6—Alzheimer's disease	8.05e-06	0.000167	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS1—Alzheimer's disease	8.02e-06	0.000166	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ENO1—Alzheimer's disease	8.02e-06	0.000166	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INPP5D—Alzheimer's disease	7.97e-06	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.92e-06	0.000164	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	7.86e-06	0.000163	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	7.82e-06	0.000162	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—BCHE—Alzheimer's disease	7.63e-06	0.000158	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS1—Alzheimer's disease	7.55e-06	0.000156	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ENO1—Alzheimer's disease	7.55e-06	0.000156	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—BCHE—Alzheimer's disease	7.45e-06	0.000154	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PLCB1—Alzheimer's disease	7.2e-06	0.000149	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AKT1—Alzheimer's disease	7.1e-06	0.000147	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.07e-06	0.000146	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PLCB1—Alzheimer's disease	7.03e-06	0.000145	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—BCHE—Alzheimer's disease	7.02e-06	0.000145	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCA1—Alzheimer's disease	6.98e-06	0.000144	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCA1—Alzheimer's disease	6.82e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CHAT—Alzheimer's disease	6.8e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—TPI1—Alzheimer's disease	6.8e-06	0.000141	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	6.74e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	6.71e-06	0.000139	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	6.63e-06	0.000137	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MAOB—Alzheimer's disease	6.52e-06	0.000135	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	6.42e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	6.27e-06	0.00013	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LPL—Alzheimer's disease	6.14e-06	0.000127	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—A2M—Alzheimer's disease	6.06e-06	0.000125	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARGC1A—Alzheimer's disease	6.02e-06	0.000124	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—HMOX1—Alzheimer's disease	5.99e-06	0.000124	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	5.87e-06	0.000121	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—HMOX1—Alzheimer's disease	5.85e-06	0.000121	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	5.54e-06	0.000114	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	5.53e-06	0.000114	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	5.51e-06	0.000114	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LPL—Alzheimer's disease	5.48e-06	0.000113	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LPL—Alzheimer's disease	5.35e-06	0.000111	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ACHE—Alzheimer's disease	5.27e-06	0.000109	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	5.21e-06	0.000108	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CALM1—Alzheimer's disease	5.16e-06	0.000107	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—APOE—Alzheimer's disease	5.15e-06	0.000106	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.1e-06	0.000105	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LPL—Alzheimer's disease	5.04e-06	0.000104	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ENO1—Alzheimer's disease	4.94e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	4.94e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—MTHFR—Alzheimer's disease	4.93e-06	0.000102	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	4.84e-06	0.0001	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—MTHFR—Alzheimer's disease	4.82e-06	9.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CALM1—Alzheimer's disease	4.61e-06	9.53e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—APOE—Alzheimer's disease	4.59e-06	9.5e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—BCHE—Alzheimer's disease	4.59e-06	9.49e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CAV1—Alzheimer's disease	4.55e-06	9.41e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	4.54e-06	9.38e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CALM1—Alzheimer's disease	4.5e-06	9.3e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—APOE—Alzheimer's disease	4.48e-06	9.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARG—Alzheimer's disease	4.48e-06	9.27e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CAV1—Alzheimer's disease	4.44e-06	9.19e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—INS—Alzheimer's disease	4.4e-06	9.09e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	4.33e-06	8.96e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CALM1—Alzheimer's disease	4.24e-06	8.77e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—APOE—Alzheimer's disease	4.22e-06	8.74e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.2e-06	8.68e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CAV1—Alzheimer's disease	4.19e-06	8.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARG—Alzheimer's disease	4e-06	8.27e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—INS—Alzheimer's disease	3.92e-06	8.11e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.9e-06	8.08e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NOS3—Alzheimer's disease	3.86e-06	7.97e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—INS—Alzheimer's disease	3.83e-06	7.92e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARG—Alzheimer's disease	3.68e-06	7.61e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	3.62e-06	7.48e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—INS—Alzheimer's disease	3.61e-06	7.46e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	3.6e-06	7.45e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	3.53e-06	7.29e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NOS3—Alzheimer's disease	3.44e-06	7.12e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NOS3—Alzheimer's disease	3.36e-06	6.95e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.3e-06	6.81e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NOS3—Alzheimer's disease	3.16e-06	6.54e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PTGS2—Alzheimer's disease	3.15e-06	6.51e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PTGS2—Alzheimer's disease	3.07e-06	6.35e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	2.97e-06	6.14e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.89e-06	5.99e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CALM1—Alzheimer's disease	2.77e-06	5.73e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—APOE—Alzheimer's disease	2.76e-06	5.71e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CAV1—Alzheimer's disease	2.74e-06	5.66e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.41e-06	4.98e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—INS—Alzheimer's disease	2.36e-06	4.88e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.07e-06	4.28e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	1.89e-06	3.91e-05	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AKT1—Alzheimer's disease	1.77e-06	3.66e-05	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AKT1—Alzheimer's disease	1.58e-06	3.27e-05	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.54e-06	3.19e-05	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.45e-06	3.01e-05	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AKT1—Alzheimer's disease	9.51e-07	1.97e-05	CbGpPWpGaD
